Skip to content
Threat Brief

← All advisories

CVE-2019-7256

Critical 9.8KEV · exploitedPublic exploitFix status unknown

Nice Linear eMerge E3-Series OS Command Injection Vulnerability

Record last updated

CVSS score

9.8

Critical on a 0 to 10 scale

EPSS, chance of exploitation in 30 days

97%

Among the highest-scored CVEs. A prediction, not evidence.

CISA remediation deadline

950days overdue

Passed 950 days ago for U.S. federal agencies

Description

Linear eMerge E3-Series devices allow Command Injections.

Weakness: CWE-78

Patching and mitigation

Patch status
Unknown: no source documents a fix
Mitigation
None documented
Vendor guidance
linear-solutions.com (opens in a new tab)

Affected products

VendorProductAffected versionsFixed inPer
NiceLinear eMerge E3-SeriesNot documentedNot documentedCISA KEV

Timeline

  1. Disclosure

    CVE record published by mitre

    Source: CVE Program (opens in a new tab)

  2. 25 Mar 2024KEV

    Added to the CISA Known Exploited Vulnerabilities catalog

    Source: CISA KEV (opens in a new tab)

  3. 25 Mar 2024Exploitation

    Exploitation confirmed by CISA KEV

    Source: CISA KEV (opens in a new tab)

Vendor guidance and references

Public exploit code

Exploit or proof-of-concept code is publicly available on Exploit-DB. Shown as a prioritization and defensive-testing signal — treat exploit code as hostile and run it only against systems you are authorized to test.